XML 86 R72.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings Per Share - Summary (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Numerator:      
Net loss attributable to Surgery Partners, Inc. $ (70.9) $ (116.1) $ (74.8)
Less: amounts allocated to participating securities (10.3) (39.5) (35.7)
Net loss attributable to common stockholders (81.2) (155.6) (110.5)
Net loss attributable to common stockholders (diluted) $ (81.2) $ (155.6) $ (110.5)
Denominator:      
Weighted average shares outstanding - basic (shares) [1] 72,427 48,776 48,280
Weighted average shares outstanding - diluted (shares) [1] 72,427 48,776 48,280
Basic (in USD per share) [1] $ (1.12) $ (3.19) $ (2.29)
Diluted (in USD per share) [1] $ (1.12) $ (3.19) $ (2.29)
Stock options      
Denominator:      
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive (shares) 1,920 712 0
Restricted shares      
Denominator:      
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive (shares) 1,452 981 67
[1] The impact of potentially dilutive securities for all periods were not considered because the effect would be anti-dilutive in those periods.